Geert Cauwenbergh, President & CEO at RXi Pharmaceuticals Corp (RXII), bought 10,000 shares at $0.44 ($4K) on 2017-10-02, disclosed to the SEC on 2017-10-02.
Open-market purchase of $4k RXII by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.44 | 2,700 | $1K | 26.5% |
| 2 | $0.45 | 7,100 | $3K | 71.4% |
| 3 | $0.46 | 200 | $92 | 2.1% |
| Total | $0.45 avg | 10,000 | $4K | 100% |
| Filing → |
| RXII | BUY | 2017-04-26 | $7K | — | Filing → |
| RXII | BUY | 2017-03-20 | $8K | — | Filing → |
| RXII | BUY | 2017-02-21 | $7K | — | Filing → |